Abstract: The present invention discloses a method for a Mobile Mobility Entity (MME) to carry out mutual authentication with a group of Machine Type Communication (MTC) devices. The method can comprise receiving group-related authentication data from a leader; transmitting the received information and Serving Network-ID, an identification number of the MME, to a HSS; receiving from the HSS a random value, an Authentication Vector and information of group members; broadcasting the random value and the first authentication token to the MTC device group based on information received from the HSS; receiving from the leader a leader authentication response that the leader generates by using a local master key value calculated by using the first secret key value; authenticating the leader by comparing the leader authentication response with a leader authentication value received from the HSS; and authenticating members within the MTC device group according to the leader authentication result.

Abstract: A transmitting method, a transmitter, a receiver and an associated scheduling method for control signal and data signal are provided. The transmitting method includes following steps. Firstly, a first control power and a first data power are respectively allocated to a first control signal and a first data signal which are to be transmitted with a first sub-carrier in a first time duration. The first control power and the first data power are different. The first control signal and the first data signal are multiplexed by superimposing the first control power and the first data power before the multiplexed first control signal and the multiplexed first data signal are transmitted.

Abstract: There is provided a device for attachment to an object for determining whether the device has been tampered with. The device has a body, removably attachable to an object, and configured to maintain a substantially fixed form or shape when attached to an object. A transducer is provided, connected to the body, configured to detect a change of form of the body. An indicator, connected to the transducer is configured to store the position of the body when attached to an object and indicate if the body has changed position after it has been attached.

Abstract: Disclosed is a photo diode. The photo diode includes: at least two branched waveguides configured to receive beating signals; absorbing layers disposed in vertical directions to the waveguides, and disposed while being spaced apart from distal ends of the waveguides by a predetermined interval; and one or more intermediate layers formed based on the distal ends of the waveguides and disposed with the absorbing layers at upper end of the one or more intermediate layers.

Abstract: Ammonia precursor refilling device including a container storing an ammonia precursor in solid form; the container being configured to fit within a first volume during storage and to be enlarged to a second volume which is larger than the first volume; the container being provided with an opening which is closed by an opening mechanism; the second volume being measured for allowing the container to be filled through the opening with water in an amount sufficient to allow the ammonia precursor in solid form to be at least partially dissolved to form an ammonia precursor solution.

Abstract: The present invention relates to a catalyst for synthesizing ethylenimine as well as a preparation method and application thereof. The related catalyst comprises a carrier and metal ions loaded on the carrier; the carrier is a composite oxide comprising titanium, silicon and phosphorus elements; the metal ions are magnesium ions, iron ions and cesium ions; the molar ratio of the magnesium ions to the iron ions to the cesium ions is (1-10):1:0.1; the mass of all metal ions is 0.5-10 percent of that of the carrier. In the related preparation method, a catalyst precursor is roasted at the temperature of 350-650° C., so that the catalyst is obtained; the catalyst precursor is the mixture of the carrier, soluble salt of magnesium, soluble salt of iron and soluble salt of cesium. The present invention also provides the application of the catalyst to synthesis of the ethylenimine by using amino alcohol as the raw material. Compared with a common catalyst which has the requirement on the temperature of over 400° C.

Abstract: A communication system includes a two-dimensional array of a plurality of plasmonic nano-antennas. Each plasmonic nano-antenna supports a surface plasmon polariton wave. A plurality of communications elements each excite a corresponding one of the plasmonic nano-antennas, thereby causing a surface plasmon polariton wave that corresponds to a signal to form on each of the plasmonic nano-antennas.

Abstract: The present disclosure includes: a communication module; a memory that stores a secret key encryption and restoration program; and a processor that executes the program, wherein when a request for restoration of a secret key is received from a user, the processor restores the secret key of which restoration is requested on the basis of restoration information received from each of a key management server and one or more trusted devices according to execution of the program, the secret key of the user is generated and encrypted by the processor in response to the request from the user, and the restoration information is generated corresponding to the secret key and then transmitted to each of the key management server and the one or more trusted devices through the communication module.

Abstract: The present invention relates to a new pharmaceutical composition containing a combination of 5-aminosalicylic acid and nicotinamide or related compounds. The combination is believed to beneficially influence the intestinal microbiota and/or reduce gastrointestinal inflammation. In certain embodiments, the pharmaceutical composition is partially or entirely released into the small intestine or large intestine.

Abstract: A method is provided for loading or reloading a decomposition unit of an SCR system, the SCR system being mounted on board a vehicle and including a filler pipe in communication with the decomposition unit. The method is such that at least one capsule containing at least one protein component adapted to decompose ammonia precursor is introduced through the filler pipe and is then guided through the filler pipe towards the decomposition unit.

Abstract: The invention relates to the detection of genomic variants using next generation sequencing platforms, and increasing the positive predictive value and/or sensitivity of detection. The invention relates to methods and systems for detecting the presence or absence of at least one specific genetic variant, including an allelic variant, in a biological sample. Accurately detecting genetic variants can lead to more accurate diagnosis, prognosis, treatment, and/or prevention of various conditions and disease, including cancer.

Abstract: Provided herein are methods of treating a subject with cancer comprising administering to the subject a death receptor agonist. Also provided herein are methods of screening a breast cancer cell for responsiveness to a DR5 agonist. Further provided herein are antibodies that selectively bind an N-terminal CARD of DDX3, a DDX3 lacking an N-terminal CARD, and an 80 kDa baculovirus TAP repeat (BIR).

Abstract: A method of producing a metal carbonate from an ultramafic rock material is provided. The method includes providing an ultramafic rock material comprising a metal silicate; reacting the ultramafic rock material with an acid to form a mixture comprising a salt of the metal; contacting the mixture comprising a salt of the metal with oxygen so as to aerate impurities in the mixture and/or to remove residual acid from the mixture; heating the resultant mixture to decompose the salt of the metal to form metal oxide; and reacting the metal oxide with aqueous ammonium carbonate to obtain the metal carbonate. A system for producing a metal carbonate from ultramafic rock material is also provided.

Abstract: The present invention relates to methods for the treatment of hepatic disorders in a subject in need thereof. More specifically, the methods of the invention are based on the administration, preferably, systemic administration, of a therapeutically effective amount of at least one biocompatible alginate biomaterial, any modification thereof and any combination thereof. The invention further provides methods for sustaining serum albumin levels, and/or reducing serum AST and ALT, in subjects suffering from hepatic disorder. Still further, the invention provides methods for reducing apoptosis and inducing cell proliferation in a damaged liver tissue of a subject suffering of hepatic disorder, using the alginate biomaterial described by the invention.

Abstract: A separator for an oil well produced fluid comprises a housing and a tube group arranged within the housing. The tube group includes a plurality of horizontal pipes in a layered arrangement along a vertical direction, and a plurality of vertical pipes which allows adjacent layers of the horizontal pipes to be in fluid communication with each other. The plurality of horizontal pipes shares an inlet pipe in communication with the outside of the housing, and each of the horizontal pipes has a respective outlet. The separator is configured in such a manner that the horizontal pipes in an upper layer, a middle layer, and a lower layer are respectively used as oil pipes, water pipes, and sediment pipes.

Abstract: A method for forming a welding spout of a plastic tank from a multilayer parison, during blowing of the parison for manufacturing the tank. The method includes, in a blowing mold including two cavities and an insert, one of the cavities delimiting a recess for forming the welding spout, the recess having a mouth opening opposite the insert: providing a push member on the insert opposite the mouth of the recess of the cavity, capable of assuming a first position set hack from the recess and a second position in which the push member occupies a portion of the mouth of the recess; positioning the push member in the first position thereof; blowing the parison to match a shape of the cavities; during creeping of the parison towards the inside of the recess, moving the push member into the second position thereof.

Abstract: The invention provides a method for reducing oxidative damage in a mammal, a removed organ, or a cell in need thereof. The method comprises administering an effective amount of an aromatic cationic peptide. The aromatic cationic peptide has (a) at least one net positive charge; (b) a minimum of three amino acids; (c) a maximum of about twenty amino acids, (d) a relationship between the minimum number of net positive charges (pm) and the total number of amino acid residues (r) wherein 3 pm is the largest number that is less than or equal to r+1; (e) a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (pt) wherein 3a or 2a is the largest number that is less than or equal to pt+1, except that when a is 1, pt may also be 1; and (f) at least one tyrosine or tryptophan amino acid.

Abstract: A method of assaying or monitoring the determining immunological competence of a subject, particularly for determining immunological competence in a subject, including but not limited to a transplant recipient, is provided. The method comprises measuring the levels of antibodies in a sample obtained from a subject to poly-guanine oligonucleotides.

Abstract: The present invention relates to compounds of formula (I), combinations and uses thereof for disease therapy, or a pharmaceutically acceptable salt, solvate or polymorph thereof, including all tautomers and stereoisomers thereof wherein R1 represents optionally substituted alkyl (wherein optional substituents include one or more substituents each independently selected from C1-6alkoxy); optionally substituted carbocyclyl (wherein optional substituents include one or more substituents each independently selected from C1-6alkyl, C1-6alkoxy, C1-6haloalkyl, C1-6haloalkoxy and halo); or -alkylaryl; R2 represents H; or alkyl; R3 represents H; or alkyl; U, V and W represent —(CH2)—; or U and V together represent —CH?CH— and W represents C?O; Y represents aryl; heteroaryl; optionally substituted carbocyclyl (wherein optional substituents include one or more substituents each independently selected from C1-6alkyl, C1-6alkoxy, C1-6haloalkyl, C1-6haloalkoxy and halo); or optionally substituted heterocyclyl (wherein opti